Dividends Calendar Earnings Calendar

BXRX | Baudax Bio

Baudax Bio
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Malvern, Pennsylvania, United States

Trade prices

  • Volume:
  • Market Cap: 5.36M
  • Prev closed: 3.48
  • Open: 3.51
  • High: 3.61
  • Low: 3.39
  • 52 week low: 2.16
  • 52 week high: 10.14
  • Dividends:No Dividends

Next ER: August 18, 2022  Before Market Opens



Top Stories (BXRX)

    Company Profile

    Baudax Bio is a pharmaceutical company focused on developing and commercializing innovative products for patients in acute care settings. We are committed to bringing clinically meaningful therapeutic options to patients, health care providers, and payers, such as ANJESO® (meloxicam) injection, which was approved by the U.S. Food and Drug Administration (FDA) in February 2020. ANJESO is indicated for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Because of delayed onset of analgesia, ANJESO alone is not recommended for use when rapid onset of analgesia is required. We believe we can create value for healthcare providers, patients and shareholders through our portfolio of products, which also includes a robust pipeline of product candidates. In addition, we continue to evaluate acquisition and licensing opportunities which align with our core acute care focus.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 14, 2022
    August 11, 2022-0.6917 / -1.27300K / 773K
    May 4, 2022-3.76 / -1.85422K / 577K
    March 16, 202210.03 / -5.25400K / 625K
    November 4, 2021-0.2 / -0.155281K / 700K
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Mar 21, 2022 1.9900 1.8900
    2.0500
    1.8701
    565.19K 5.85%
    Mar 18, 2022 1.8800 1.8300
    1.9400
    1.8000
    343.94K 2.17%
    Mar 17, 2022 1.8400 1.7500
    1.8800
    1.7100
    363.15K 5.75%
    Mar 16, 2022 1.7400 1.6700
    1.7650
    1.6100
    387.57K 7.41%
    Mar 15, 2022 1.6200 1.6300
    1.6700
    1.5600
    362.33K 1.25%
    Mar 14, 2022 1.6000 1.6800
    1.7300
    1.5500
    364.38K -2.44%
    Mar 11, 2022 1.6400 1.7600
    1.8000
    1.6000
    420.31K -8.89%
    Mar 10, 2022 1.8000 1.8400
    1.8400
    1.6993
    345.16K -3.23%
    Mar 9, 2022 1.8600 1.6900
    2.0800
    1.6500
    2.66M 14.81%
    Mar 8, 2022 1.6200 1.6000
    1.6399
    1.4900
    859.89K 2.53%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2015
    • Employees:24

    News

    News for (BXRX)

    This company doesn't provide a dividend.


    Talk about Baudax Bio below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 18, 2022 (Same day)

    cx amat ntes.ch el px rost agro kss crbp sptn dds rfp 


    Jump to (Finance sites)

    Their Official Profiles 

    LinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.